ChromoGenics AB

OSTO:CHRO (Sweden)  
kr 9.72 (-0.61%) Sep 20
At Loss
P/B:
0.95
Market Cap:
kr 64.45M ($ 6.34M)
Enterprise V:
kr 84.66M ($ 8.32M)
Volume:
930.00
Avg Vol (2M):
5.81K
Trade In:
Volume:
930.00
At Loss
Avg Vol (2M):
5.81K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for ChromoGenics AB ( OSTO:CHRO ) from 2017 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. ChromoGenics AB stock (OSTO:CHRO) PE ratio as of Sep 21 2024 is 0. More Details

ChromoGenics AB (OSTO:CHRO) PE Ratio (TTM) Chart

To

ChromoGenics AB (OSTO:CHRO) PE Ratio (TTM) Historical Data

Total 1292
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
ChromoGenics AB PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-22 At Loss 2024-07-22 At Loss
2024-09-20 At Loss 2024-07-19 At Loss
2024-09-19 At Loss 2024-07-18 At Loss
2024-09-18 At Loss 2024-07-17 At Loss
2024-09-17 At Loss 2024-07-16 At Loss
2024-09-16 At Loss 2024-07-15 At Loss
2024-09-13 At Loss 2024-07-12 At Loss
2024-09-12 At Loss 2024-07-11 At Loss
2024-09-11 At Loss 2024-07-10 At Loss
2024-09-10 At Loss 2024-07-09 At Loss
2024-09-09 At Loss 2024-07-08 At Loss
2024-09-06 At Loss 2024-07-05 At Loss
2024-09-05 At Loss 2024-07-04 At Loss
2024-09-04 At Loss 2024-07-03 At Loss
2024-09-03 At Loss 2024-07-02 At Loss
2024-09-02 At Loss 2024-07-01 At Loss
2024-08-30 At Loss 2024-06-28 At Loss
2024-08-29 At Loss 2024-06-27 At Loss
2024-08-28 At Loss 2024-06-26 At Loss
2024-08-27 At Loss 2024-06-25 At Loss
2024-08-26 At Loss 2024-06-24 At Loss
2024-08-23 At Loss 2024-06-20 At Loss
2024-08-22 At Loss 2024-06-19 At Loss
2024-08-21 At Loss 2024-06-18 At Loss
2024-08-20 At Loss 2024-06-17 At Loss
2024-08-19 At Loss 2024-06-14 At Loss
2024-08-16 At Loss 2024-06-13 At Loss
2024-08-15 At Loss 2024-06-12 At Loss
2024-08-14 At Loss 2024-06-11 At Loss
2024-08-13 At Loss 2024-06-10 At Loss
2024-08-12 At Loss 2024-06-07 At Loss
2024-08-09 At Loss 2024-06-05 At Loss
2024-08-08 At Loss 2024-06-04 At Loss
2024-08-07 At Loss 2024-06-03 At Loss
2024-08-06 At Loss 2024-05-31 At Loss
2024-08-05 At Loss 2024-05-30 At Loss
2024-08-02 At Loss 2024-05-29 At Loss
2024-08-01 At Loss 2024-05-28 At Loss
2024-07-31 At Loss 2024-05-27 At Loss
2024-07-30 At Loss 2024-05-24 At Loss
2024-07-29 At Loss 2024-05-23 At Loss
2024-07-26 At Loss 2024-05-22 At Loss
2024-07-25 At Loss 2024-05-21 At Loss
2024-07-24 At Loss 2024-05-20 At Loss
2024-07-23 At Loss 2024-05-17 At Loss

ChromoGenics AB (OSTO:CHRO) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
ChromoGenics AB develops and produces dynamic glass with controllable optical properties in Sweden and internationally. The company offers ConverLight, an electrochromic glass, which provides UV protection for use in single glass pane and insulating glass unit solutions. This glass is suitable for new construction, reconstruction, and renovation and offers ultraviolet protection that reduces the risk of fading interiors.